Effect of short-term treatment with bumetanide, quinapril and low-sodium diet on dogs with moderate congestive heart failure

Australian Veterinary Journal

Volumn 79, Issue 2, 2001, Pages 102-105

  Martinez Alcaine, M A ^a   Ynaraja, E ^a   Corbera, J A ^b   Montoya, J A ^b  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b UNIVERSITY OF LAS PALMAS DE GRAN CANARIA   (Spain)

Author keywords

Bumetanide; Cardiology; Congestive heart failure; Dog; Low sodium diet; Quinapril

Indexed keywords

ANIMALIA; CANIS FAMILIARIS;

BUMETANIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ISOQUINOLINE DERIVATIVE; QUINAPRIL; TETRAHYDROISOQUINOLINE DERIVATIVE;

ANIMAL; ANIMAL DISEASE; ARTICLE; CONGESTIVE HEART FAILURE; DIET THERAPY; DOG; DOG DISEASE; FEMALE; HOSPITALIZATION; MALE; MITRAL VALVE REGURGITATION; PROSPECTIVE STUDY; SODIUM RESTRICTION; TREATMENT OUTCOME;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; BUMETANIDE; DIET, SODIUM-RESTRICTED; DIURETICS; DOG DISEASES; DOGS; FEMALE; HEART FAILURE, CONGESTIVE; ISOQUINOLINES; MALE; MITRAL VALVE INSUFFICIENCY; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TETRAHYDROISOQUINOLINES; TREATMENT OUTCOME;

EID: 0035260767     PISSN: 00050423     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1751-0813.2001.tb10709.x     Document Type: Article

References (27)

1. Kittleson MD. Pathophysiology and treatment of heart failure. In: Miller MS, Tilley LP, editors. Manual of canine and feline cardiology. 2nd edn. Saunders, Philadelphia, 1995:343-370.
2. Keene BW, Bonagura JD. Therapy of heart failure. In: Bonagura JD, editor. Kirk's current veterinary therapy XII. Saunders, Philadelphia, 1995:780-786.
3. Fox PR. Angiotensin converting enzyme inhibitors. In: Bonagura JD, editor. Kirk's current veterinary therapy XII. Saunders, Philadelphia, 1995:786-791.
4. Brater DC. Disposition and response to bumetanide and frusemide. Am J Cardiol 1986;57:20-25.
5. Puschett JB. Clinical pharmacology implications in diuretic selection. Am J Cardiol 1986;57:6A-13A.
6. Gross DR. Drugs affecting fluid and electrolyte balance. In: Booth NH, McDonald LE, editors. Veterinary pharmacology and therapeutics. 6th edn. Iowa State University Press, Ames, 1988:562-565.
7. Galli C, Uguccioni M, Concezzi M et al. Evaluation of the efficacy and tolerability of quinapril monotherapy in mild and moderate arterial hypertension. Minerva Cardioangiol 1991;39:41-45.
8. Keene BW, Rush JE. Therapy of heart failure. In: Ettinger EJ, Feldman EC, editors. Textbook of veterinary internal medicine. 4th edn. Saunders, Philadelphia, 1995:867-892.
9. Latta D, Finnamore VP, Dalton K, Allman S. An open randomized comparative study of a low-strength frusemide/amiloride combination and bumetanide/potassium chloride in the treatment of mild congestive cardiac failure. J Intern Med Res 1990;18:10 B-16 B.
10. Silke B. Central haemodynamic effects of diuretic therapy in chronic heart failure. Cardiovasc Drugs Ther 1993;7:45-53.
11. Ward A, Heel RC. Bumetanide. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use. Drugs 1984; 28: 426-464.
12. Townsend JN, West JN, Davies MK, Litter WA. Effect of quinapril on blood pressure and heart rate in congestive heart failure. Am J Cardiol 1992;69:1587-1590.
13. Littman MP, Dobratz KJ. Hypertensive and hypotensive disorders. In: Ettinger EJ, Feldman EC editors. Textbook of veterinary internal medicine. 4th edn. Saunders, Philadelphia, 1995:93-100.
14. Wadworth AN, Brogden RN. Quinapril. A review of its pharmacological properties and therapeutic efficacy in cardiovascular disorders. Drugs 1991; 41:378-399.
15. Cetnarowsky-Cropp AB. Quinapril: a new second generation ACE inhibitor. Ann Pharmacother 1991;25:499-504.
16. Materson BJ. Adverse effects of angiotensin converting enzyme inhibitors in antihypertensive therapy with focus on quinapril. Am J Cardiol 1992;69:6C-53C
17. Morisse B, Kersten U. The efficacy and safety of quinapril and captopril in the treatment of canine heart failure. Kleintierpraxis 1994;39: 295-308.
18. Whelton A. An overview of national patterns and preferences in diuretic selection. Am J Cardiol 1986;57:2A-5A.
19. Gottlieb SS, Robinson S, Weir MR, Fisher ML, Krichten CM. Determinants of the renal response to ACE inhibition in patients with congestive heart failure. Am Heart 1992;124:131-136.
20. Hoyer J, Schulte KL, Lenz T. Clinical pharmacokinetics of angiotensin converting enzyme (ACE) inhibitor in renal failure. Clin Pharmacokin 1993;24:230-254.
21. Riegger GA. Effects of quinapril on exercise tolerance in patients with mild to moderate heart failure. Eur Heart J 1991;12:705-711.
22. Cobb M, Michell AR. Plasma electrolyte concentrations in dogs receiving diuretic therapy for cardiac failure. J Small Anim Pract 1992;33:526-529.
23. Wilcox CS, Loon NR, Ameer B, Limacher MC. Renal and hemodynamic responses to bumetanide in hypertension: effects of nitrendipine. Kidney Int 1989;36:719-725.
24. Brater DC. Clinical pharmacology of loop diuretics in health and disease. Eur Heart J 1992; 13 G:10-14.
25. Flamenbaum W. Diuretic use in the elderly: potential for diuretic induced hypokalemia. Am J Cardiol 1986;57:38-43.
26. Ramsay F, Crawford RJ, Allman S, Bailey R, Martin A. An open comparative study of two diuretic combinations, frusemide/amiloride (Frumide) and bumetanide/potassium chloride (Buriner) in the treatment of congestive cardiac failure in hospital out-patients. Curr Med Res Opin 1988;10:682-689.
27. Narins RG, Chusid P. Diuretic use in clinical care. Am J Cardiol 1986;57:26 A-32 A.